Abiopharma

🔍 Banerjee Subhashis (Executive)

Company: Artiva Biotherapeutics, Inc. (ARTV)

Report Date: 2026-08-18

Detailed Transactions and Holdings:

• Acquired 429 shares of Common Stock at $1.92 per share (Direct)
  Date: 2026-08-18 | Code: M | equity_swap_involved: false | shares_owned_after: 145,392.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 429 shares of Common Stock at $12.0 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: false | shares_owned_after: 144,963.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 429 shares of Employee Stock Option (Right to Buy) at $1.92 per share (Derivative)
  Date: 2026-08-18 | Code: M | Expires: 2035-04-07 | equity_swap_involved: false | shares_owned_after: 79,571.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The reported transactions occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 14, 2026.
• F2: 25% of the shares initially subject to the option vested and became exercisable on April 8, 2026, and the balance of the shares subject to the option are vesting and becoming exercisable at a rate of 1/36th per month over the following 36 months.